Ceva Sante Animale successfully regained the feliway.site domain after a respondent used it for a fake storefront. The Panel ordered the transfer of the domain, citing clear trademark infringement and bad-faith impersonation of the company’s official site.
Case Snapshot
| Case Number | D2026-2643 |
|---|---|
| Complainant | Ceva Sante Animale |
| Respondent | CIERRA JUNE |
| Disputed Domain | feliway.site |
| Threat Tactic | Fake Stores |
| Decision Date | 2026-08-17 |
| Panelist | Philippe Gilliéron |
| Outcome | Transfer |
| Official Source | https://www.wipo.int/amc/en/domains/search/text.jsp?case=D2026-2643 |
Operational Mimicry and Fraudulent Storefront Risk
The use of the disputed domain feliway.site represents a targeted effort to compromise brand integrity through the deployment of a deceptive storefront. By creating a website that mirrored and replicated the official Feliway portal—including the unauthorized use of trademarks and logos—the respondent engaged in high-fidelity impersonation designed to mislead consumers. This tactic exploits the reputation of an established animal healthcare entity, leveraging consumer familiarity with the brand to facilitate the distribution of unauthorized, purported products at discounted prices. Such fraudulent activity creates a direct threat to the Complainant’s market share and presents an inherent risk to animal health, as customers are lured into transactions on platforms that lack official vetting.
This case underscores the complexities of managing brand assets in a decentralized domain environment where bad actors employ privacy services to obfuscate their true identities. While the Complainant identified and challenged the infringing activity, the use of anonymization services can complicate recovery and delay enforcement. The respondent’s refusal to engage with the cease and desist process, coupled with the intentional mimicry of legitimate e-commerce infrastructure, demonstrates a coordinated approach to financial gain at the expense of consumer trust. For brand owners, this highlights the necessity of continuous monitoring for sites that replicate web architecture, as these platforms serve as focal points for direct revenue diversion and the potential erosion of long-standing customer relationships.
Panel Reasoning: Addressing Brand Impersonation and Fraudulent Storefronts
The Panel evaluated the dispute under the three standard UDRP criteria, beginning with the threshold requirement of confusing similarity. Ceva Sante Animale successfully demonstrated that the disputed domain ‘feliway.site’ incorporates its protected ‘Feliway’ trademark in its entirety. Given that the Complainant holds multiple global registrations for the mark dating back to 1996, the Panel readily concluded that the disputed domain creates a high risk of consumer confusion by mimicking the primary branding associated with the Complainant’s established animal healthcare products.
Regarding the second element, the Panel found that the Respondent possesses no rights or legitimate interests in the domain. The evidence showed that the Respondent is not commonly known by the name ‘Feliway’, nor did it receive authorization to utilize the trademark. Crucially, the domain resolved to a website that mirrored the Complainant’s official platform, a tactic that does not constitute a bona fide offering of goods or services. This unauthorized replication of trademarks and logos further substantiates the lack of any legitimate commercial interest.
The determination of bad faith was centered on the Respondent’s use of the site as an opportunistic storefront. By imitating the Complainant’s professional website to offer ‘Feliway’ products at discounted prices, the Respondent exhibited clear fraudulent intent. The Panel noted that this activity was designed to deceive consumers into engaging with an unauthorized and potentially deceptive commercial entity. The Respondent’s failure to provide any defense or rebuttal to these specific contentions of fraud further supported the Panel’s finding of bad faith.
The resolution of this case highlights the risks posed by fake shop tactics, where bad actors leverage the trust built by global brands to divert revenue and compromise consumer protection. By confirming the domain’s transfer, the Panel reinforced the necessity of protecting trademark holders against the unauthorized digital replication of their assets. This outcome underscores that while domain registration can be used to facilitate impersonation, the UDRP provides a definitive mechanism to disrupt these fraudulent operations when a registrant fails to establish any legitimate link to the trademarked term.
Strategic Countermeasures Against Impersonation-Based Fraud
Ceva Sante Animale’s successful recovery of the ‘feliway.site’ domain underscores the importance of documenting specific operational mimicry as evidence of bad faith. By submitting clear proof that the respondent’s website replicated the official brand interface—including unauthorized use of logos and trademarked content—the complainant established a comprehensive record of deceit. This evidence directly refuted any potential claim of a bona fide offering of goods, as the site was designed solely to capture traffic and execute financial transactions for non-genuine products. The inclusion of the January 2026 cease and desist letter in the filing further demonstrated the complainant’s proactive attempt to resolve the matter, providing the panel with a clear timeline of the respondent’s non-compliance.
The complainant’s strategy also benefited from leveraging a strong, global trademark portfolio dating back to 1996, which provided a robust legal foundation for its UDRP filings. By demonstrating that the disputed domain was registered specifically to exploit the ‘Feliway’ mark, the complainant effectively navigated the jurisdictional complexity of the dispute. The respondent’s failure to reply to the administrative proceedings allowed the panel to rely entirely on the complainant’s detailed contentions regarding the respondent’s lack of rights or legitimate interests. This outcome highlights that for brand owners, the most persuasive evidence often lies in contrasting the official, authorized domain infrastructure with the visual and functional markers of the infringer’s fraudulent storefront.
Practical Recommendations
- Conduct comprehensive visual captures of the infringing site—including full-page screenshots of product listings and checkout flows—immediately upon discovery to provide robust evidence of ‘fake shop’ impersonation.
- Monitor domain registration patterns for keywords alongside your primary trademark, as perpetrators often register multiple variations simultaneously to build a network of fraudulent storefronts.
- Leverage the UDRP ‘no response’ outcome by documenting the ignored cease and desist correspondence as part of your evidence, which reinforces the finding of bad faith and supports a swift panel decision.
- Utilize domain registrar WHOIS verification early in the dispute process to identify discrepancies between the listed registrar contact and the actual operator, aiding in the accurate identification of the respondent for legal filings.
Frequently Asked Questions (FAQ)
Why was the domain ‘feliway.site’ considered confusingly similar to the complainant’s brand?
The panel determined that the disputed domain name was confusingly similar because it entirely incorporated the ‘Feliway’ trademark, which is protected by numerous international and regional registrations owned by Ceva Sante Animale.
What evidence did the panel use to establish that the respondent had no legitimate interest in the domain?
The respondent had no rights or legitimate interests because it was not commonly known by the name, possessed no trademark rights for ‘Feliway’, and was never authorized by Ceva Sante Animale to use its intellectual property.
How was bad faith demonstrated in the operation of the ‘feliway.site’ website?
Bad faith was confirmed by the respondent’s creation of a mirror site that replicated the complainant’s official website, used unauthorized logos, and offered purported Feliway products at discounted prices, indicating a clear intent to deceive consumers for financial gain.
What was the tactical outcome of this UDRP case for Ceva Sante Animale?
Following the respondent’s failure to reply to the complainant’s contentions or the cease and desist letter, the panel ordered the immediate transfer of the domain ‘feliway.site’ to Ceva Sante Animale, effectively shutting down the fraudulent storefront.
Found a fake shop using your brand?
Protect your customers and revenue from unauthorized sites impersonating your products. Learn how our UDRP enforcement strategies can help you secure infringing domains and shut down fraudulent storefronts.
This case note is for informational purposes only and is not legal advice.
